Rapid Dose Therapeutics Inc. signed a letter of intent to acquire certain assets of CTT Pharmaceutical Holdings, Inc. (OTCPK:CTTH) on May 17, 2017. Rapid Dose Therapeutics Inc. entered into an agreement to acquire certain assets of CTT Pharmaceutical Holdings, Inc. (OTCPK:CTTH) on May 29, 2017. Assets includes patents, technology and processes for an oral fast-dissolving drug delivery system. Acquisition is subjected to US and Canadian securities laws including the due diligence investigations.

Rapid Dose Therapeutics Inc. cancelled the acquisition of certain assets of CTT Pharmaceutical Holdings, Inc. (OTCPK:CTTH) on October 31, 2018. The agreement terminated because the RDT being unable to satisfy its due diligence investigations and obtain sufficient comfort with respect to CTT's representations regarding its purported intellectual property.